BTG3 and juvenile idiopathic arthritis: Presence of certain autoantibodies is often used for discrimination between patient subgroups in other fields of rheumatology, but due to the limited knowledge about JIA autoantigens the routinely evaluated antibodies in JIA care are limited to ANA, RF, and antibodies towards cyclic citrullinated peptides (anti-CCP).